Rare Disease Treatment Market
Rare Disease Treatment Market Study by Haematology, Genetic Diseases, Neurological Diseases, Oncology, Infectious Diseases, Inflammatory Diseases, Metabolic Diseases, and Others from 2024 to 2034
Analysis of Rare Disease Treatment Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
- FACT10029MR
- 11 Apr 2024
- Healthcare
- 170 Pages
- 30 Tables
- 127 Figures
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Market Background
- 5. Market Context
- 6. Global Market - Pricing Analysis
- 7. Global Market Value Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Therapeutic Area
- 8.1. Hematology
- 8.2. Genetic Diseases
- 8.3. Neurological Diseases
- 8.4. Oncology
- 8.5. Infectious Diseases
- 8.6. Inflammatory Diseases
- 8.7. Metabolic Diseases
- 8.8. Pulmonary Diseases
- 8.9. Kidney Diseases
- 8.10. Musculoskeletal Diseases
- 8.11. Endocrine Diseases
- 8.12. Topical Diseases
- 9. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Drug Type
- 9.1. Originator Drugs
- 9.2. Generic Drugs
- 10. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Drug Class
- 10.1. Biologics
- 10.2. Organic Compounds
- 11. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Mode of Administration
- 11.1. Injectables
- 11.2. Oral
- 12. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Distribution Channel
- 12.1. Hospital Pharmacies
- 12.2. Specialty Treatment Pharmacies
- 12.3. Retail Pharmacies
- 13. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, by Region
- 13.1. North America
- 13.2. Latin America
- 13.3. Europe
- 13.4. East Asia
- 13.5. South Asia
- 13.6. Oceania
- 13.7. Middle East and Africa (MEA)
- 14. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 16. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 17. Rest of the World Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 18. Key and Emerging Countries Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 19. Market Structure Analysis
- 20. Competition Analysis
- 20.1. Novartis AG
- 20.2. AbbVie
- 20.3. Bristol Myers Squibb
- 20.4. BioMarin
- 20.5. Amgen Inc.
- 20.6. PTC Therapeutics
- 20.7. AstraZeneca
- 20.8. GlaxoSmithKline Plc
- 20.9. Amgen Inc.
- 20.10. Pfizer Inc.
- 20.11. Johnson & Johnson
- 21. Assumptions and Acronyms Used
- 22. Research Methodology
List Of Table
Table 01: Global Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Therapeutic Area
Table 02: Global Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Type
Table 03: Global Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Class
Table 04: Global Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Mode of Administration
Table 05: Global Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Distribution Channel
Table 06: Global Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Mode of Administration Age Group
Table 07: Global Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Region
Table 08: North America Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 09: North America Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Therapeutic Area
Table 10: North America Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Class
Table 11: North America Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Type
Table 12: North America Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Mode of Administration
Table 13: North America Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Distribution Channel
Table 14: Europe Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 15: Europe Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Therapeutic Area
Table 16: Europe Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Class
Table 17: Europe Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Type
Table 18: Europe Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Mode of Administration
Table 19: Europe Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Distribution Channel
Table 20: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Country
Table 21: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Therapeutic Area
Table 22: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Class
Table 23: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Type
Table 24: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Mode of Administration
Table 25: Middle East and Africa Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Distribution Channel
Table 26: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Therapeutic Area
Table 27: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Class
Table 28: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Drug Type
Table 29: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Mode of Administration
Table 30: Rest of the World Market Size (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034, By Distribution Channel
List Of Figures
Figure 01: Global Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 02: Global Market Absolute $ Opportunity, 2024 to 2034
Figure 03: Global Market Share Analysis (%), By Therapeutic Area, 2024 & 2034
Figure 04: Global Market Y-o-Y Analysis (%), By Therapeutic Area, 2024 to 2034
Figure 05: Global Market Attractiveness Analysis By Therapeutic Area, 2024 to 2034
Figure 06: Global Market Share Analysis (%), By Drug Type, 2024 & 2034
Figure 07: Global Market Y-o-Y Analysis (%), By Drug Type, 2024 to 2034
Figure 08: Global Market Attractiveness Analysis By Drug Type, 2024 to 2034
Figure 09: Global Market Share Analysis (%), By Drug Class, 2024 & 2034
Figure 10: Global Market Y-o-Y Analysis (%), By Drug Class, 2024 to 2034
Figure 11: Global Market Attractiveness Analysis By Drug Class, 2024 to 2034
Figure 12: Global Market Share Analysis (%), By Mode of Administration, 2024 & 2034
Figure 13: Global Market Y-o-Y Analysis (%), By Mode of Administration, 2024 to 2034
Figure 14: Global Market Attractiveness Analysis By Mode of Administration, 2024 to 2034
Figure 15: Global Market Share Analysis (%), By Distribution Channel, 2024 & 2034
Figure 16: Global Market Y-o-Y Analysis (%), By Distribution Channel , 2024 to 2034
Figure 17: Global Market Attractiveness Analysis, By Distribution Channel, 2024 to 2034
Figure 18: Global Market Share Analysis (%), By Mode of Administration Age Group, 2024 & 2034
Figure 19: Global Market Y-o-Y Analysis (%), By Mode of Administration Age Group, 2024 to 2034
Figure 20: Global Market Attractiveness Analysis By Mode of Administration Age Group, 2024 to 2034
Figure 21: Global Market Share Analysis (%), By Region, 2024 & 2034
Figure 22: Global Market Y-o-Y Analysis (%), By Region, 2024 to 2034
Figure 23: Global Market Attractiveness Analysis, By Region, 2024 to 2034
Figure 24: North America Market Value Share, By Therapeutic Area, 2024 (E)
Figure 25: North America Market Value Share, By Drug Classs 2024 (E)
Figure 26: North America Market Value Share, By Drug Type, 2024 (E)
Figure 27: North America Market Value Share, By Mode of Administration, 2024 (E)
Figure 28: North America Market Value Share, By Distribution Channel, 2024 (E)
Figure 29: North America Market Value Share, By Country, 2024 (E)
Figure 30: North America Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 31: North America Market Attractiveness Analysis By Therapeutic Area, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis By Drug Class, 2024 to 2034
Figure 33: North America Market Attractiveness Analysis By Drug Type, 2024 to 2034
Figure 34: North America Market Attractiveness Analysis By Mode of Administration, 2024 to 2034
Figure 35: North America Market Attractiveness Analysis By Distribution Channel, 2024 to 2034
Figure 36: North America Market Attractiveness Analysis By Country, 2024 to 2034
Figure 37: Europe Market Value Share, By Therapeutic Area, 2024 (E)
Figure 38: Europe Market Value Share, By Drug Classs 2024 (E)
Figure 39: Europe Market Value Share, By Drug Type, 2024 (E)
Figure 40: Europe Market Value Share, By Mode of Administration, 2024 (E)
Figure 41: Europe Market Value Share, By Distribution Channel, 2024 (E)
Figure 42: Europe Market Value Share, By Country, 2024 (E)
Figure 43: Europe Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 44: Europe Market Attractiveness Analysis By Therapeutic Area, 2024 to 2034
Figure 45: Europe Market Attractiveness Analysis By Drug Class, 2024 to 2034
Figure 46: Europe Market Attractiveness Analysis By Drug Type, 2024 to 2034
Figure 47: Europe Market Attractiveness Analysis By Mode of Administration, 2024 to 2034
Figure 48: Europe Market Attractiveness Analysis By Drug Type, 2024 to 2034
Figure 49: Europe Market Attractiveness Analysis By Country, 2024 to 2034
Figure 50: Middle East and Africa Market Value Share, By Therapeutic Area, 2024 (E)
Figure 51: Middle East and Africa Market Value Share, By Drug Class, 2024 (E)
Figure 52: Middle East and Africa Market Value Share, By Drug Type, 2024 (E)
Figure 53: Middle East and Africa Market Value Share, By Mode of Administration, 2024 (E)
Figure 54: Middle East and Africa Market Value Share, By Distribution Channel, 2024 (E)
Figure 55: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 56: Middle East and Africa Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 57: Middle East and Africa Market Attractiveness Analysis By Therapeutic Area, 2024 to 2034
Figure 58: Middle East and Africa Market Attractiveness Analysis By Drug Class, 2024 to 2034
Figure 59: Middle East and Africa Market Attractiveness Analysis By Drug Type, 2024 to 2034
Figure 60: Middle East and Africa Market Attractiveness Analysis By Mode of Administration, 2024 to 2034
Figure 61: Middle East and Africa Market Attractiveness Analysis By Distribution Channel, 2024 to 2034
Figure 62: Middle East and Africa Market Attractiveness Analysis By Country, 2024 to 2034
Figure 63: Rest of the World Market Value Share, By Therapeutic Area, 2024 (E)
Figure 64: Rest of the World Market Value Share, By Drug Classs 2024 (E)
Figure 65: Rest of the World Market Value Share, By Drug Type, 2024 (E)
Figure 66: Rest of the World Market Value Share, By Mode of Administration, 2024 (E)
Figure 67: Rest of the World Market Value Share, By Distribution Channel, 2024 (E)
Figure 68: Rest of the World Market Value (US$ Mn) Analysis 2018 to 2023 and Forecast 2024 to 2034
Figure 69: Rest of the World Market Attractiveness Analysis By Therapeutic Area, 2024 to 2034
Figure 70: Rest of the World Market Attractiveness Analysis By Drug Class, 2024 to 2034
Figure 71: Rest of the World Market Attractiveness Analysis By Drug Type, 2024 to 2034
Figure 72: Rest of the World Market Attractiveness Analysis By Mode of Administration, 2024 to 2034
Figure 73: Rest of the World Market Attractiveness Analysis By Distribution Channel, 2024 to 2034
Figure 74: United States Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 75: United States Market Value Share, By Drug Class, 2024 & 2034
Figure 76: United States Market Value Share, By Drug Type, 2024 & 2034
Figure 77: United States Market Value Share, By Mode of Administration Age Group, 2024 & 2034
Figure 78: United States Market Value Share, By Distribution Channel, 2024 & 2034
Figure 79: United States Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Canada Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 81: Canada Market Value Share, By Drug Class, 2024 & 2034
Figure 82: Canada Market Value Share, By Drug Type, 2024 & 2034
Figure 83: Canada Market Value Share, By Mode of Administration Age Group, 2024 & 2034
Figure 84: Canada Market Value Share, By Distribution Channel, 2024 & 2034
Figure 85: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: United Kingdom Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 87: United Kingdom Market Value Share, By Drug Class, 2024 & 2034
Figure 88: United Kingdom Market Value Share, By Drug Type, 2024 & 2034
Figure 89: United Kingdom Market Value Share, By Mode of Administration Age Group, 2024 & 2034
Figure 90: United Kingdom Market Value Share, By Distribution Channel, 2024 & 2034
Figure 91: United Kingdom Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: Germany Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 93: Germany Market Value Share, By Drug Class, 2024 & 2034
Figure 94: Germany Market Value Share, By Drug Type, 2024 & 2034
Figure 95: Germany Market Value Share, By Mode of Administration Age Group, 2024 & 2034
Figure 96: Germany Market Value Share, By Distribution Channel, 2024 & 2034
Figure 97: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: France Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 99: France Market Value Share, By Drug Class, 2024 & 2034
Figure 100: France Market Value Share, By Drug Type, 2024 & 2034
Figure 101: France. Market Value Share, By Mode of Administration Age Group, 2024 & 2034
Figure 102: France Market Value Share, By Distribution Channel, 2024 & 2034
Figure 103: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: Italy Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 105: Italy Market Value Share, By Drug Class, 2024 & 2034
Figure 106: Italy Market Value Share, By Drug Type, 2024 & 2034
Figure 107: Italy Market Value Share, By Mode of Administration Age Group, 2024 & 2034
Figure 108: Italy Market Value Share, By Distribution Channel, 2024 & 2034
Figure 109: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: Spain Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 111: Spain Market Value Share, By Drug Class, 2024 & 2034
Figure 112: Spain Market Value Share, By Drug Type, 2024 & 2034
Figure 113: Spain Market Value Share, By Mode of Administration Age Group, 2024 & 2034
Figure 114: Spain Market Value Share, By Distribution Channel, 2024 & 2034
Figure 115: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: GCC Countries. Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 117: GCC Countries Market Value Share, By Drug Class, 2024 & 2034
Figure 118: GCC Countries Market Value Share, By Drug Type, 2024 & 2034
Figure 119: GCC Countries Market Value Share, By Mode of Administration, 2024 & 2034
Figure 120: GCC Countries Market Value Share, By Distribution Channel, 2024 & 2034
Figure 121: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: South Africa Market Value Share, By Therapeutic Area, 2024 & 2034
Figure 123: South Africa Market Value Share, By Drug Class, 2024 & 2034
Figure 124: South Africa Market Value Share, By Drug Type, 2024 & 2034
Figure 125: South Africa Market Value Share, By Mode of Administration Age Group, 2024 & 2034
Figure 126: South Africa Market Value Share, By Distribution Channel, 2024 & 2034
Figure 127: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Rare Disease Treatment Market